Abstract: Stable valepotriate compositions are produced by a process wherein impurities are removed from the pharmaceutically active extract of the valerianacea fruits, followed by a mixing with pharmaceutically acceptable sheathing materials and the formation of microspheres therefrom.

Abstract: The new water-soluble substance designated by the number 41,200 RP, is obtained from cells of Micrococcus sedogenes, M 78 strain (NRRL B-3505), and is particularly useful in human or veterinary therapy for increasing resistance to infections of various origins and for stimulating the natural defences of the organism.

Abstract: A combination of lineatin, ethanol and optionally other naturally occurring components in trees which are normally attacked by Ambrosia beetles, and the use thereof as an attractant for combatting Ambrosia beetles (Trypodendron), particularly T. lineatum.

Abstract: Montmorillonite, either alone or when combined with other materials, is highly effective in the treatment of dermatomycosis pedis. Even better results are obtained when the composition contains about 80% montmorillonite, about 20% pyroligneous acid and a very small quantity of papain enzyme. About 0.5% of lysozyme hydrochloride may also be added. The compositions are not only effective for the treatment of both wet and dry athlete's foot, but also in deodorizing the unpleasant odors of socks and the inside of shoes.

Abstract: In a process for extracting embryonic calf skin which includes initially grinding the calf skin, extracting the same, separating the resulting extract and lyophilizing the separated extract, the extraction stage is carried out in an extraction medium comprising an aqueous solution having an acid pH, at a temperature between 60.degree.-75.degree. C., for a period of at least 3 hours. The resulting extract which exhibits cicatrisive activity is employed in cosmetic and pharmaceutical compositions.

Abstract: The invention relates to a solvent vehicle for therapeutics comprising a dialkyl ester of adipic acid and, optionally, DMSO, which is particularly useful for therapeutic materials having a low solubility or being insoluble in water.The invention further relates to pharmaceutical compositions which are suitable for parenteral administration, especially by intramuscular injection, comprising a therapeutically active material dissolved in said solvent vehicle.Solvent vehicles containing di-n-butyl adipate and DMSO and, if desired, one or more adjuvants, are preferred.Particularly useful are pharmaceutical compositions for the prophylaxis and/or treatment of diseases caused by internal parasites, which can be administered by intramuscular injection. A preferred embodiment of the invention is an injectable composition against distomatosis (liver fluke disease) containing proportionally 12.5 g 4,6'-dichloro-4',6-dinitro-2,2'-methylenediphenol and 30 g of DMSO, completed with di-n-butyl adipate to 100 cm.sup.3.

Abstract: An odor absorbing composition comprising(a) from 0.5-45% by weight of diethylene glycol;(b) from 0.5-45% by weight propylene glycol;(c) from 0.5-30% by weight triethylene glycol;(d) from 1-50% by weight glycerine;(e) from 0.1-20% by weight of a diethanolamide of a C.sub.16 -C.sub.18 unsaturated fatty acid, and(f) from 0.05-5% by weight of an unsaturated fatty acid.

Abstract: A process and composition for coloring substances and tissues containing keratin, by means of an agent or co-reactant having a ketone or aldehyde function. An amino-acid, in particular a thio-amino-acid, is contacted with the substance to be colored. The composition can be in the form of a solution or a suspension containing the amino-acid, applicable separately from or together with the co-reactant of known type based on a ketone or aldehyde. The invention is useful in cosmetics, for tanning the skin or coloring the hair or nails. It is also applicable to the coloration of various articles, in particular hair in general, feathers, horn, shell etc.